60PD Inhibition of pEGFR in paired tumour biopsies from TKI treatment-naïve EGFR mutant NSCLC patients treated with gefitinib (EGFR inhibitor) or gefitinib in combination with durvalumab (anti-PD-L1).
Journal Article
Full Text
Duke Authors
Cited Authors
- Yeh, T; Jacobs, V; Angell, H; Geradts, J; Hou, J; Karakunnel, J; Barrett, C
Published Date
- April 2016
Published In
Volume / Issue
- 11 / 4 Suppl
Start / End Page
- S80 - S81
PubMed ID
- 27198416
Pubmed Central ID
- 27198416
Electronic International Standard Serial Number (EISSN)
- 1556-1380
Digital Object Identifier (DOI)
- 10.1016/S1556-0864(16)30173-3
Language
- eng
Conference Location
- United States